Log in to save to my catalogue

Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa...

Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6cf4a8b566d54d9aab3793f39b9ef0a5

Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa bacteriophage therapy for cystic fibrosis

About this item

Full title

Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa bacteriophage therapy for cystic fibrosis

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-11, Vol.14 (1), p.29727-14, Article 29727

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Phase contrast x-ray imaging (PCXI) provides high-contrast images of weakly-attenuating structures like the lungs. PCXI, when paired with 4D X-ray Velocimetry (XV), can measure regional lung function and non-invasively assess the efficacy of emerging therapeutics. Bacteriophage therapy is an emerging antimicrobial treatment option for lung diseases...

Alternative Titles

Full title

Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa bacteriophage therapy for cystic fibrosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6cf4a8b566d54d9aab3793f39b9ef0a5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6cf4a8b566d54d9aab3793f39b9ef0a5

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-80326-0

How to access this item